Mallat Ziad, Ait-Oufella Hafid, Tedgui Alain
Institut National de la Santé et de la Recherche Médicale, Inserm U689, Cardiovascular Research Center Lariboisière, and University Paris 7, Paris, France.
Trends Cardiovasc Med. 2007 May;17(4):113-8. doi: 10.1016/j.tcm.2007.03.001.
Atherosclerosis is an inflammatory disease of the arterial wall where both innate and adaptive T-cell-driven immunoinflammatory responses contribute to disease development. Recent studies from several groups suggest that subtypes of T cells, called regulatory T cells, previously shown to maintain immunologic tolerance, control the development and progression of atherosclerosis. Here, we summarize the current knowledge on the regulatory T-cell response in the context of atherosclerosis and the accumulating evidence for its central role in counteracting disease initiation and progression.
动脉粥样硬化是一种动脉壁的炎症性疾病,先天性和适应性T细胞驱动的免疫炎症反应均参与疾病发展。多个研究团队近期的研究表明,一种名为调节性T细胞的T细胞亚型,此前被证明可维持免疫耐受,能够控制动脉粥样硬化的发生和发展。在此,我们总结了目前关于动脉粥样硬化背景下调节性T细胞反应的知识,以及其在对抗疾病起始和进展中核心作用的越来越多的证据。